Which cardiac conditions are indications for antibiotic prophylaxis to prevent infective endocarditis?

Which Cardiac Conditions Require Endocarditis Prophylaxis

Antibiotic prophylaxis for infective endocarditis should be reserved exclusively for patients at highest risk of adverse outcomes: those with prosthetic cardiac valves (including transcatheter valves or prosthetic repair material), previous infective endocarditis, or specific high-risk congenital heart disease. 1, 2

High-Risk Cardiac Conditions Requiring Prophylaxis

The following conditions warrant antibiotic prophylaxis before dental procedures involving gingival manipulation, periapical tooth region manipulation, or oral mucosa perforation:

1. Prosthetic Cardiac Material

• Any prosthetic heart valve (mechanical or bioprosthetic)
• Transcatheter-implanted valves (TAVR/TAVI)
• Any prosthetic material used for cardiac valve repair
• Rationale: These patients have the highest mortality risk from IE, and infected prosthetic material typically requires surgical removal with associated high morbidity 1, 2

2. Previous Infective Endocarditis

• Any patient with a history of IE, regardless of the original cardiac substrate
• Rationale: Recurrence carries extremely high mortality risk 1, 2

3. Specific Congenital Heart Disease

• Any cyanotic congenital heart disease (repaired or unrepaired)
• Congenital heart disease repaired with prosthetic material:
  • During first 6 months post-repair (until endothelialization occurs) 2
  • Beyond 6 months if residual defects persist at the repair site 2
• Rationale: Complex cyanotic disease in young patients has the worst prognosis, and prosthetic material in newborns/infants carries particularly high risk 2

Conditions That Do NOT Require Prophylaxis

The guidelines explicitly state prophylaxis is not recommended for 1, 2:

• Mitral valve prolapse (even with regurgitation)
• Bicuspid aortic valve (even with stenosis or regurgitation)
• Rheumatic heart disease
• Acquired valvular disease (aortic stenosis, mitral regurgitation, etc.)
• Cardiac transplantation without valvular disease
• Hypertrophic cardiomyopathy
• Most forms of congenital heart disease including:
  • Isolated atrial septal defect
  • Ventricular septal defect (repaired or unrepaired)
  • Patent ductus arteriosus
  • Post-Mustard/Senning procedures for transposition

Important Caveat on Practice Patterns

Despite clear guidelines, research shows many experienced cardiologists continue prescribing prophylaxis for moderate-risk conditions like rheumatic heart disease with aortic insufficiency and bicuspid aortic valves 3. This practice is not evidence-based and contributes to antibiotic resistance.

Key Procedural Considerations

Dental Procedures Requiring Prophylaxis (in high-risk patients only):

• Gingival manipulation
• Periapical tooth region procedures
• Oral mucosa perforation

Dental Procedures NOT Requiring Prophylaxis:

• Local anesthetic injections in non-infected tissue
• Superficial caries treatment
• Suture removal
• Dental X-rays
• Orthodontic appliance placement/adjustment
• Shedding of deciduous teeth 1

Non-Dental Procedures

Prophylaxis is NOT recommended for 1:

• Bronchoscopy or laryngoscopy
• Endotracheal intubation
• Gastroscopy or colonoscopy
• Cystoscopy
• Vaginal or cesarean delivery
• Transesophageal echocardiography
• Skin and soft tissue procedures

Evidence Strength and Rationale

The 2015 ESC guidelines 1 and 2007 AHA guidelines 2 represent a major paradigm shift from earlier recommendations. The key principle is that prophylaxis should target patients at highest risk of death from IE, not simply those at increased risk of acquiring IE.

While one older case-control study suggested 91% protective efficacy 4, and a recent 2024 meta-analysis showed reduced IE risk in high-risk patients (RR 0.41) 5, no randomized controlled trials exist. The guidelines acknowledge prophylaxis effectiveness is unproven but reasonable for highest-risk patients (Class IIa recommendation) 1.

Critical Pitfall to Avoid

Do not prescribe prophylaxis based on "lifetime risk of acquiring IE." The absolute incidence of IE is extremely low even in conditions like MVP, and widespread antibiotic use promotes resistant organisms (particularly viridans streptococci and enterococci) that cause IE 2. The restriction to highest-risk patients balances potential benefit against antibiotic resistance and adverse drug reactions.